Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer
Clinical trial NCT03799679 · UNKNOWN
Trial details
- NCT number
- NCT03799679
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-26
- Primary completion
- 2019-11-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.